The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
New targets for mucosal healing and therapy in inflammatory bowel diseases
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Colombel, J., Sandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,245
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
Johansson, M. E. V., Larsson, J. M. H., & Hansson, G. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006451107 · Cited by 1,452
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
Self-citationAtreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationKruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
HELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227
Self-citationCancer risk in patients with inflammatory bowel disease: A population-based study
Bernstein, C. N., Blanchard, J. F., Kliewer, E., & Wajda, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z · Cited by 1,165
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Self-citationProgressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., & Rutgeerts, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051586 · Cited by 1,060
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043
Self-citationReduced Paneth cell α-defensins in ileal Crohn's disease
Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505256102 · Cited by 988
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J.-F., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.05.048 · Cited by 940
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Colombel, J. F., Rutgeerts, P., Reinisch, W., Esser, D., Wang, Y., Lang, Y., Marano, C. W., Strauss, R., Oddens, B. J., Feagan, B. G., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.054 · Cited by 919
Methotrexate for the Treatment of Crohn's Disease
Feagan, B. G., Rochon, J., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Gillies, R., Hopkins, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320503 · Cited by 911
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Günther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M. J., Hedrick, S. M., Tenzer, S., Neurath, M. F., et al. (2011) · Nature · doi:10.1038/nature10400 · Cited by 884
Self-citationRachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 848
Self-citationTiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Self-citationInterleukin-23 drives innate and T cell–mediated intestinal inflammation
Hue, S., Ahern, P., Buonocore, S., Kullberg, M. C., Cua, D. J., McKenzie, B. S., Powrie, F., & Maloy, K. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061099 · Cited by 823
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
Self-citationTofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Rho GTPases and the control of cell behaviour
Hall, A. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330891 · Cited by 792
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y., & Bevins, C. L. (2003) · Nature · doi:10.1038/nature01520 · Cited by 765
Trichuris suis therapy in Crohn’s disease
Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R., & Weinstock, J. V. (2005) · Gut · doi:10.1136/gut.2004.041749 · Cited by 762
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Liao, W., Lin, J.-X., & Leonard, W. J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.003 · Cited by 745
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.06.010 · Cited by 727
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Self-citationVan den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
Schnitzler, F., Fidder, H., Ferrante, M., Noman, M., Arijs, I., Van Assche, G., Hoffman, I., Van Steen, K., Vermeire, S., & Rutgeerts, P. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20927 · Cited by 673
Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S., & Strober, W. (2002) · Immunity · doi:10.1016/s1074-7613(02)00453-3 · Cited by 650
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Intestinal barrier dysfunction in inflammatory bowel diseases
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J., & Radford-Smith, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20539 · Cited by 627
Lee, J., Mo, J.-H., Katakura, K., Alkalay, I., Rucker, A. N., Liu, Y.-T., Lee, H.-K., Shen, C., Cojocaru, G., Shenouda, S., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1500 · Cited by 623
The role of Th1/Th2 polarization in mucosal immunity
Neurath, M. F., Finotto, S., & Glimcher, L. H. (2002) · Nature Medicine · doi:10.1038/nm0602-567 · Cited by 623
Self-citationTrichuris suis therapy for active ulcerative colitis: a randomized controlled trial
Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R. A., & Weinstock, J. V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.005 · Cited by 613
Neurath, M. F., Weigmann, B., Finotto, S., Glickman, J., Nieuwenhuis, E., Iijima, H., Mizoguchi, A., Mizoguchi, E., Mudter, J., Galle, P. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011956 · Cited by 607
Self-citationIL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease
Kobayashi, T., Okamoto, S., Hisamatsu, T., Kamada, N., Chinen, H., Saito, R., Kitazume, M. T., Nakazawa, A., Sugita, A., Koganei, K., et al. (2008) · Gut · doi:10.1136/gut.2007.135053 · Cited by 570
ADAM17: a molecular switch to control inflammation and tissue regeneration
Scheller, J., Chalaris, A., Garbers, C., & Rose-John, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.005 · Cited by 526
T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells
Fahlén, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A., & Powrie, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040685 · Cited by 518
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Fukata, M., Michelsen, K. S., Eri, R., Thomas, L. S., Hu, B., Lukasek, K., Nast, C. C., Lechago, J., Xu, R., Naiki, Y., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00328.2004 · Cited by 506
Izcue, A., Coombes, J. L., & Powrie, F. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00423.x · Cited by 474
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
Uhlig, H. H., Coombes, J., Mottet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., Fontenot, J. D., Ramsdell, F., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5852 · Cited by 463
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
Kleinschek, M. A., Boniface, K., Sadekova, S., Grein, J., Murphy, E. E., Turner, S. P., Raskin, L., Desai, B., Faubion, W. A., de Waal Malefyt, R., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081712 · Cited by 460
Clinical implications of mucosal healing for the management of IBD
Pineton de Chambrun, G., Peyrin-Biroulet, L., Lémann, M., & Colombel, J.-F. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.203 · Cited by 459
Sandborn, W. J., & Hanauer, S. B. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199905000-00008 · Cited by 454
Toll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., & Raz, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22996 · Cited by 451
Dignass, A. U., & Podolsky, D. K. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90136-z · Cited by 446
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
Self-citationDignass, A., Lynch-Devaney, K., Kindon, H., Thim, L., & Podolsky, D. K. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117332 · Cited by 422
Davidson, N. J., Leach, M. W., Fort, M. M., Thompson-Snipes, L., Kühn, R., Müller, W., Berg, D. J., & Rennick, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.241 · Cited by 402
Su, L., Nalle, S. C., Shen, L., Turner, E. S., Singh, G., Breskin, L. A., Khramtsova, E. A., Khramtsova, G., Tsai, P., Fu, Y., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.011 · Cited by 397
Desreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hébuterne, X., Bouhnik, Y., Nachury, M., Brun, V., Bastian, H., Belmonte, N., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.116 · Cited by 384
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis
Rachmilewitz, D., Karmeli, F., Takabayashi, K., Hayashi, T., Leider-Trejo, L., Lee, J., Leoni, L. M., & Raz, E. (2002) · Gastroenterology · doi:10.1053/gast.2002.32994 · Cited by 384
Hovhannisyan, Z., Treatman, J., Littman, D. R., & Mayer, L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.002 · Cited by 339
Epithelial restitution and wound healing in inflammatory bowel disease
Sturm, A., & Dignass, A. U. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.348 · Cited by 334
Hayashi, A., Sato, T., Kamada, N., Mikami, Y., Matsuoka, K., Hisamatsu, T., Hibi, T., Roers, A., Yagita, H., Ohteki, T., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.013 · Cited by 331
Fuss, I. J., Becker, C., Yang, Z., Groden, C., Hornung, R. L., Heller, F., Neurath, M. F., Strober, W., & Mannon, P. J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194183.92671.b6 · Cited by 326
Self-citationAutophagy and the Immune System
Kuballa, P., Nolte, W. M., Castoreno, A. B., & Xavier, R. J. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074948 · Cited by 326
Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.
Podolsky, D. K., Lobb, R., King, N., Benjamin, C. D., Pepinsky, B., Sehgal, P., & deBeaumont, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116575 · Cited by 320
Zeissig, S., Bojarski, C., Buergel, N., Mankertz, J., Zeitz, M., Fromm, M., & Schulzke, J. D. (2004) · Gut · doi:10.1136/gut.2003.036632 · Cited by 305
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
Vandenbroucke, K., de Haard, H., Beirnaert, E., Dreier, T., Lauwereys, M., Huyck, L., Van Huysse, J., Demetter, P., Steidler, L., Remaut, E., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.116 · Cited by 289
Siegmund, B., Fantuzzi, G., Rieder, F., Gamboni-Robertson, F., Lehr, H.-A., Hartmann, G., Dinarello, C. A., Endres, S., & Eigler, A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.4.r1264 · Cited by 288
Efficient colonic mucosal wound repair requires Trem2 signaling
Seno, H., Miyoshi, H., Brown, S. L., Geske, M. J., Colonna, M., & Stappenbeck, T. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803343106 · Cited by 284
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
Hering, N. A., Fromm, M., & Schulzke, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224568 · Cited by 275
Mitoma, H., Horiuchi, T., Hatta, N., Tsukamoto, H., Harashima, S.-I., Kikuchi, Y., Otsuka, J., Okamura, S., Fujita, S., & Harada, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.060 · Cited by 270
Anti–interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
Fuss, I. J., Marth, T., Neurath, M. F., Pearlstein, G. R., Jain, A., & Strober, W. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70392-6 · Cited by 268
Self-citationThe inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Hansson, G. C., & Johansson, M. E. V. (2010) · Gut Microbes · doi:10.4161/gmic.1.1.10470 · Cited by 267
Chassaing, B., Rolhion, N., Vallée, A. D., Salim, S. Y., Prorok-Hamon, M., Neut, C., Campbell, B. J., Söderholm, J. D., Hugot, J.-P., Colombel, J.-F., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44632 · Cited by 265
Wound healing of intestinal epithelial cells
Iizuka, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i17.2161 · Cited by 259
Atreya, R., Zimmer, M., Bartsch, B., Waldner, M. J., Atreya, I., Neumann, H., Hildner, K., Hoffman, A., Kiesslich, R., Rink, A. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.032 · Cited by 256
Self-citationDavidson, N. J., Hudak, S. A., Lesley, R., Menon, S., Leach, M. W., & Rennick, D. M. (1998) · PubMed · Cited by 250
NFAT control of innate immunity
Fric, J., Zelante, T., Wong, A. Y. W., Mertes, A., Yu, H.-B., & Ricciardi-Castagnoli, P. (2012) · Blood · doi:10.1182/blood-2012-02-404475 · Cited by 244
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Colombel, J., Rutgeerts, P. J., Sandborn, W. J., Yang, M., Camez, A., Pollack, P. F., Thakkar, R. B., Robinson, A. M., Chen, N., Mulani, P. M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.019 · Cited by 244
Fantini, M. C. (2006) · Gut · doi:10.1136/gut.2005.072801 · Cited by 238
Peyrin-Biroulet, L., Loftus, E. V., Colombel, J.-F., & Sandborn, W. J. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21417 · Cited by 236
Etanercept for the Treatment of Rheumatoid Arthritis
Zhao, S., Mysler, E., & Moots, R. J. (2018) · Immunotherapy · doi:10.2217/imt-2017-0155 · Cited by 236
Colitis-Associated Variant of TLR2 Causes Impaired Mucosal Repair Because of TFF3 Deficiency
Podolsky, D. K., Gerken, G., Eyking, A., & Cario, E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.007 · Cited by 230
Reinisch, W., de Villiers, W., Bene, L., Simon, L., Rácz, I., Katz, S., Altorjay, I., Feagan, B., Riff, D., Bernstein, C. N., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21038 · Cited by 220
Vos, A. C. W., Wildenberg, M. E., Duijvestein, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.008 · Cited by 218
Parikh, A., Leach, T., Wyant, T., Scholz, C., Sankoh, S., Mould, D. R., Ponich, T., Fox, I., & Feagan, B. G. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21896 · Cited by 210
Erdman, S. E., Rao, V. P., Poutahidis, T., Ihrig, M. M., Ge, Z., Feng, Y., Tomczak, M. F., Rogers, A. B., Horwitz, B. H., & Fox, J. G. (2003) · PubMed · Cited by 210
Davidson, N. J., Hudak, S. A., Lesley, R. E., Menon, S., Leach, M. W., & Rennick, D. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3143 · Cited by 208
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis
Wirtz, S., Billmeier, U., Mchedlidze, T., Blumberg, R. S., & Neurath, M. F. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.040 · Cited by 207
Self-citationPoppe, D., Tiede, I., Fritz, G., Becker, C., Bartsch, B., Wirtz, S., Strand, D., Tanaka, S., Galle, P. R., Bustelo, X. R., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.640 · Cited by 204
Self-citationRegulatory macrophages induced by infliximab are involved in healing in vivo and in vitro
Vos, A. C. W., Wildenberg, M. E., Arijs, I., Duijvestein, M., Verhaar, A. P., de Hertogh, G., Vermeire, S., Rutgeerts, P., van den Brink, G. R., & Hommes, D. W. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21818 · Cited by 200
Boirivant, M., Pallone, F., Di Giacinto, C., Fina, D., Monteleone, I., Marinaro, M., Caruso, R., Colantoni, A., Palmieri, G., Sanchez, M., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.016 · Cited by 197
Epithelial Barriers in Intestinal Inflammation
John, L. J., Fromm, M., & Schulzke, J.-D. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3892 · Cited by 195
Mucins in inflammatory bowel diseases and colorectal cancer
Sheng, Y. H., Hasnain, S. Z., Florin, T. H. J., & McGuckin, M. A. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06909.x · Cited by 193
Wirtz, S. J., Finotto, S., Kanzler, S., Lohse, A. W., Blessing, M., Lehr, H. A., Galle, P. R., & Neurath, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.1884 · Cited by 192
Self-citationTargeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Thomas, S., & Baumgart, D. C. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0104-6 · Cited by 191
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Mayer, L., Sandborn, W. J., Stepanov, Y., Geboes, K., Hardi, R., Yellin, M., Tao, X., Xu, L. A., Salter-Cid, L., Gujrathi, S., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303424 · Cited by 188
Mucin Function in Inflammatory Bowel Disease: An Update
Boltin, D., Perets, T. T., Vilkin, A., & Niv, Y. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182688e73 · Cited by 181
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression
Fantini, M. C., Rizzo, A., Fina, D., Caruso, R., Sarra, M., Stolfi, C., Becker, C., MacDonald, T. T., Pallone, F., Neurath, M. F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.053 · Cited by 179
Self-citationWirtz, S. J., Finotto, S., Kanzler, S., Lohse, A. W., Blessing, M., Lehr, H. A., Galle, P. R., & Neurath, M. F. (1999) · PubMed · Cited by 179
Self-citationRetarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
Stremmel, W. (2005) · Gut · doi:10.1136/gut.2004.052316 · Cited by 176
Prantera, C., Lochs, H., Grimaldi, M., Danese, S., Scribano, M. L., & Gionchetti, P. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.032 · Cited by 176
Reinisch, W., Hommes, D. W., Van Assche, G., Colombel, J.-F., Gendre, J.-P., Oldenburg, B., Teml, A., Geboes, K., Ding, H., Zhang, L., et al. (2006) · Gut · doi:10.1136/gut.2005.079434 · Cited by 175
Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
Dorofeyev, A. E., Vasilenko, I. V., Rassokhina, O. A., & Kondratiuk, R. B. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/431231 · Cited by 171
Van den Brande, J. M. H., Koehler, T. C., Zelinkova, Z., Bennink, R. J., te Velde, A. A., ten Cate, F. J. W., van Deventer, S. J. H., Peppelenbosch, M. P., & Hommes, D. W. (2007) · Gut · doi:10.1136/gut.2006.105379 · Cited by 170
PRANTERA, C., LOCHS, H., CAMPIERI, M., SCRIBANO, M. L., STURNIOLO, G. C., CASTIGLIONE, F., & COTTONE, M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02879.x · Cited by 163
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Rutgeerts, P. J., Fedorak, R. N., Hommes, D. W., Sturm, A., Baumgart, D. C., Bressler, B. L., Schreiber, S., Mansfield, J. C., Williams, M. B., Tang, M. T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301769 · Cited by 152
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
Stolfi, C., Rizzo, A., Franzè, E., Rotondi, A., Fantini, M. C., Sarra, M., Caruso, R., Monteleone, I., Sileri, P., Franceschilli, L., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20111106 · Cited by 147
Innate immune dysfunction in inflammatory bowel disease
Gersemann, M., Wehkamp, J., & Stange, E. F. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02515.x · Cited by 143
Abatacept for Crohn's Disease and Ulcerative Colitis
Sandborn, W. J., Colombel, J., Sands, B. E., Rutgeerts, P. J., Targan, S. R., Panaccione, R., Bressler, B. L., Geboes, K., Schreiber, S., Aranda, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.010 · Cited by 142
Regulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 141
Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms
Flammer, J. R., & Rogatsky, I. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0068 · Cited by 140 · cited 1×
“For instance, corticosteroids that are used for induction of clinical remission in both CD and UC strongly suppress proinflammatory cytokine production by macrophages and T cells.(77) Furthermore, cyclosporin A and tacrolimus that are effective for induction of remission in severely active UC(78,79) and methotrexate t…”
BackgroundMonteleone, G., Fantini, M. C., Onali, S., Zorzi, F., Sancesario, G. M., Bernardini, S., Calabrese, E., Viti, F., Monteleone, I., Biancone, L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.290 · Cited by 140
Healing of intestinal inflammation by IL-22
Mizoguchi, A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22929 · Cited by 138
IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue
Leung, J. M., Davenport, M., Wolff, M. J., Wiens, K. E., Abidi, W. M., Poles, M. A., Cho, I., Ullman, T. A., Mayer, L., & Loke, P. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.31 · Cited by 137
Göke, M. N., Kanai, M., & Podolsky, D. K. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.5.g809 · Cited by 129
IL-27 promotes T cell–dependent colitis through multiple mechanisms
Cox, J. H., Kljavin, N. M., Ramamoorthi, N., Diehl, L. J., Batten, M., & Ghilardi, N. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100410 · Cited by 127
Adalimumab safety in global clinical trials of patients with Crohnʼs disease
Colombel, J., Sandborn, W. J., Panaccione, R., Robinson, A. M., Lau, W., Li, J., & Cardoso, A. T. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20956 · Cited by 127
Fischer, A., Gluth, M., Pape, U., Wiedenmann, B., Theuring, F., & Baumgart, D. C. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00183.2012 · Cited by 123
Ey, B., Eyking, A., Gerken, G., Podolsky, D. K., & Cario, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901619200 · Cited by 119
Neurath, M. F., Hildner, K., Becker, C., Schlaak, J., Barbulescu, K., Germann, T., Schmitt, E., Schirmacher, P., Haralambous, S., Pasparakis, M., et al. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00753.x · Cited by 118
Self-citationDanese, S., Fiorino, G., & Reinisch, W. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04679.x · Cited by 117
TGF-β1 and Smad7 in the regulation of IBD
Monteleone, G., Boirivant, M., Pallone, F., & MacDonald, T. T. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.55 · Cited by 116
Papadakis, K. A., Landers, C. J., Prehn, J., Kouroumalis, E., Moreno, S. T., Gutierrez-Ramos, J.-C., Hodge, M. R., & Targan, S. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.159 · Cited by 114
Cyclosporin for severe ulcerative colitis: a user's guide.
Kornbluth, A. A., Present, D. H., Lichtiger, S., et al. (1997) · PubMed · Cited by 111
Krishnan, K., Arnone, B., & Buchman, A. L. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21316 · Cited by 111
The role of IL-13 and NK T cells in experimental and human ulcerative colitis
Fuss, I. J., & Strober, W. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.40 · Cited by 111
Ho, S. B., Dvorak, L. A., Moor, R. E., Jacobson, A. C., Frey, M. R., Corredor, J., Polk, D. B., & Shekels, L. L. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.006 · Cited by 111
Atreya, R. N., & Neurath, M. (2008) · Current Drug Targets · doi:10.2174/138945008784221116 · Cited by 107
Self-citationTh17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
Monteleone, I., Sarra, M., Pallone, F., & Monteleone, G. (2012) · Current Molecular Medicine · doi:10.2174/156652412800620066 · Cited by 107
p53 Mediates TNF-Induced Epithelial Cell Apoptosis in IBD
Goretsky, T., Dirisina, R., Sinh, P., Mittal, N., Managlia, E. Z., Williams, D. B., Posca, D., Ryu, H., Katzman, R. B., & Barrett, T. A. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.016 · Cited by 106
Danese, S., Colombel, J. F., Peyrin‐Biroulet, L., Rutgeerts, P., & Reinisch, W. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12284 · Cited by 94
Th17-related cytokines: new players in the control of chronic intestinal inflammation
Monteleone, I., Pallone, F., & Monteleone, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-122 · Cited by 93
Gilbert, S., Zhang, R., Denson, L. A., Moriggl, R., Steinbrecher, K. A., Shroyer, N. F., Lin, J., & Han, X. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100192 · Cited by 92
Paclik, D., Lohse, K., Wiedenmann, B., Dignass, A. U., & Sturm, A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20499 · Cited by 89
Herrlinger, K. R., Witthoeft, T., Raedler, A., Bokemeyer, B., Krummenerl, T., Schulzke, J., Boerner, N. H., Kueppers, B., Emmrich, J., Mescheder, A., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00356.x · Cited by 88
Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion
Bringer, M.-A., Billard, E., Glasser, A.-L., Colombel, J., & Darfeuille–Michaud, A. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.156 · Cited by 87
TLR9 is important for protection against intestinal damage and for intestinal repair
II, W. A. R., Sakamoto, K., & Leifer, C. A. (2012) · Scientific Reports · doi:10.1038/srep00574 · Cited by 84
Weinstock, J. V. (2012) · Nature · doi:10.1038/491183a · Cited by 84
Vongsa, R. A., Zimmerman, N. P., & Dwinell, M. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805289200 · Cited by 83
Kawashima, R., Kawamura, Y. I., Oshio, T., Son, A., Yamazaki, M., Hagiwara, T., Okada, T., Inagaki-Ohara, K., Wu, P., Szak, S. T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.040 · Cited by 83
Sandborn, W. J., COLOMBEL, J. ‐., Frankel, M. B., Hommes, D. W., Lowder, J. N., Mayer, L., Plevy, S. E., Stokkers, P. C. F., Travis, S. P. L., Assche, G. V., et al. (2010) · Gut · doi:10.1136/gut.2009.205443 · Cited by 82
Hommes, D. W., Colombel, J., Emery, P., Greco, M., & Sandborn, W. J. (2012) · Journal of Crohn s and Colitis · doi:10.1016/s1873-9946(12)60502-9 · Cited by 81
Bernasconi, E., Favre, L., Maillard, M. H., Bachmann, D., Pythoud, C., Bouzourène, H., Croze, E., Velichko, S., Parkinson, J. F., Michetti, P., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21072 · Cited by 80
Moyer, R. A., Wendt, M. K., Johanesen, P., Turner, J. R., & Dwinell, M. B. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700595 · Cited by 80
Human beta defensin 2 promotes intestinal wound healing in vitro
Otte, J., Werner, I., Brand, S., Chromik, A. M., Schmitz, F., Kleine, M., & Schmidt, W. E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21787 · Cited by 80
Perrier, C., Hertogh, G. D., Cremer, J., Vermeire, S., Rutgeerts, P. J., Assche, G. V., Szymkowski, D. E., & Ceuppens, J. L. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23023 · Cited by 71
Etanercept for the treatment of rheumatoid arthritis
Lethaby, A. E., Lopez-Olivo, M. A., Maxwell, L. J., et al. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004525.pub2 · Cited by 70
Dignass, A. U., Stow, J. L., & Babyatsky, M. W. (1996) · Gut · doi:10.1136/gut.38.5.687 · Cited by 69
Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis
Lee, J., Mo, J., Shen, C., Rucker, A. N., & Raz, E. (2006) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3280118272 · Cited by 69
Stremmel, W., Hanemann, A., Ehehalt, R., Karner, M., & Braun, A. (2010) · Digestive Diseases · doi:10.1159/000320407 · Cited by 62
Regulation of intestinal barrier function by signal transducer and activator of transcription 5b
Han, X., Ren, X., Jurickova, I., Groschwitz, K. R., Pasternak, B. A., Xu, H., Wilson, T. A., Hogan, S. P., & Denson, L. A. (2008) · Gut · doi:10.1136/gut.2007.145094 · Cited by 58
Pickard, K. M., Bremner, A. R., Gordon, J. N., & MacDonald, T. T. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.10.009 · Cited by 58
Dotan, I., Rachmilewitz, D., Schreiber, S., Eliakim, R., van der Woude, C. J., Kornbluth, A. A., Buchman, A. L., Bar-Meir, S., Bokemeyer, B., Goldin, E., et al. (2010) · Gut · doi:10.1136/gut.2009.179994 · Cited by 57
Biosimilars in IBD: hope or expectation?
Gecse, K., Khanna, R., van den Brink, G. R., Ponsioen, C., Lowenberg, M., Jairath, V., Travis, S., Sandborn, W., Feagan, B., & D'Haens, G. (2013) · Gut · doi:10.1136/gutjnl-2012-303824 · Cited by 56
Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer
Fournier, P., & Schirrmacher, V. (2012) · BioDrugs · doi:10.1007/s40259-012-0008-z · Cited by 55
Inflammatory Bowel Disease: Dysfunction of Autophagy?
Scharl, M. M., & Rogler, G. (2012) · Digestive Diseases · doi:10.1159/000342588 · Cited by 53
Cantacessi, C., Young, N. D., Nejsum, P. L., Jex, A. R., Campbell, B. E., Hall, R. S., Thamsborg, S. M., Scheerlinck, J. Y., & Gasser, R. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023590 · Cited by 48
Leukocyte Traffic Blockade as a Therapeutic Strategy in Inflammatory Bowel Disease
Bamias, G., Clark, D. L., & Rivera–Nieves, J. (2013) · Current Drug Targets · doi:10.2174/13894501113149990158 · Cited by 46
Sands, B. E., Sandborn, W. J., Creed, T., Dayan, C. M., Dhanda, A., Assche, G. A. V., Greguš, M., Sood, A., Choudhuri, G., Stempien, M. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.043 · Cited by 42
Musch, E., Lutfi, T., von Stein, P., Zargari, A., Admyre, C., Malek, M., Löfberg, R., & von Stein, O. D. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23019 · Cited by 41
Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
Nitto, D. D., Sarra, M., Cupi, M. L., Pallone, F., & Monteleone, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210794079164 · Cited by 39
Daniel, C., Gerlach, K., Vaeth, M., Neurath, M. F., & Weigmann, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28329 · Cited by 38
Self-citationHildner, K., Finotto, S., Becker, C., Schlaak, J., Schirmacher, P., Galle, P. R., Märker‐Hermann, E., & Neurath, M. F. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.01022.x · Cited by 37
Self-citationCommon alleles that influence autophagy and the risk for inflammatory bowel disease
Gardet, A., & Xavier, R. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.08.001 · Cited by 35
Foersch, S., Waldner, M. J., & Neurath, M. F. (2012) · Digestive Diseases · doi:10.1159/000341692 · Cited by 29
Self-citationHofmann, C., Dunger, N., Grunwald, N., Hämmerling, G. J., Hoffmann, P., Schölmerich, J., Falk, W., & Obermeier, F. (2010) · Gut · doi:10.1136/gut.2009.193177 · Cited by 21
Valatas, V., He, J., Rivollier, A., Kolios, G. C., Kitamura, K., & Kelsall, B. L. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.102 · Cited by 20
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
Bodger, K., & Gledhill (2013) · Biologics · doi:10.2147/btt.s30416 · Cited by 18
Tocilizumab: An lnterleukin-6 Receptor Inhibitor for the Treatment of Rheumatoid Arthritis
Plushner, S. L. (2008) · The Annals of Pharmacotherapy · doi:10.1345/aph.1l268 · Cited by 16
Etanercept in the treatment of rheumatoid arthritis
Hunt, L. H., & Emery, P. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.823154 · Cited by 14
A review and expert opinion of the use of certolizumab for Crohn's disease
Evans, A., & Lee, S. D. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.658770 · Cited by 10
Atreya, R. N., Neumann, H., Neufert, C. F., Zopf, Y., Waldner, M. J., Kießlich, R., Münster, T., Kessler, H., Maas, S., Gebhardt, B., et al. (2012) · Gastroenterology · doi:10.1016/s0016-5085(12)62054-x · Cited by 1
Self-citation
Cited by
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Regulation of tumour necrosis factor signalling: live or let die
Brenner, D., Blaser, H., & Mak, T. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3834 · Cited by 998
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Na, Y. R., Stakenborg, M., Seok, S. H., & Matteoli, G. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0172-4 · Cited by 900
Reparative inflammation takes charge of tissue regeneration
Karin, M., & Clevers, H. (2016) · Nature · doi:10.1038/nature17039 · Cited by 767
Metadata
- Authors
- Neurath, M. F.
- Venue
- Mucosal Immunology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 7
- Issue
- 1
- Pages
- 6-19
- ISSN
- 1933-0219 (ISSN-L)
- OpenAlex
- W1964815186
- Cited by
- 309
- References
- 189
- FWCI
- 16.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.